{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:59:23Z","timestamp":1781758763444,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Fundation of China","doi-asserted-by":"crossref","award":["81502535"],"award-info":[{"award-number":["81502535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1344-3","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T01:52:24Z","timestamp":1519350744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The extremity localized classic osteosarcomas have better survival than the axial non-classics"],"prefix":"10.1186","volume":"16","author":[{"given":"Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoze","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/jso.24045","volume":"112","author":"V Nataraj","year":"2015","unstructured":"Nataraj V, Batra A, Rastogi S, Khan SA, Sharma MC, Vishnubhatla S, Bakhshi S. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: a single-center experience of 237 patients. J Surg Oncol. 2015;112:662\u20138.","journal-title":"J Surg Oncol"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/annonc\/mdr491","volume":"23","author":"JS Whelan","year":"2012","unstructured":"Whelan JS, Jinks RC, McTiernan A, Sydes MR, Hook JM, Trani L, Uscinska B, Bramwell V, Lewis IJ, Nooij MA, et al. Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol. 2012;23:1607\u201316.","journal-title":"Ann Oncol"},{"key":"1344_CR3","doi-asserted-by":"crossref","unstructured":"Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res. 1991;270:8\u201314.","DOI":"10.1097\/00003086-199109000-00003"},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","volume":"40","author":"A Luetke","year":"2014","unstructured":"Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment\u2014where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523\u201332.","journal-title":"Cancer Treat Rev"},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1517\/14656566.2015.1102226","volume":"16","author":"S Ferrari","year":"2015","unstructured":"Ferrari S, Serra M. An update on chemotherapy for osteosarcoma. Expert Opin Pharmacother. 2015;16:2727\u201336.","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl 7","key":"1344_CR6","doi-asserted-by":"crossref","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","volume":"21","author":"J Ritter","year":"2010","unstructured":"Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320\u20135.","journal-title":"Ann Oncol"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12032-013-0624-6","volume":"30","author":"A Durnali","year":"2013","unstructured":"Durnali A, Alkis N, Cangur S, Yukruk FA, Inal A, Tokluoglu S, Seker MM, Bal O, Akman T, Inanc M, et al. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients. Med Oncol. 2013;30:624.","journal-title":"Med Oncol"},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1743-7563.2012.01560.x","volume":"9","author":"D Min","year":"2013","unstructured":"Min D, Lin F, Shen Z, Zheng S, Tan L, Yu W, Yao Y. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy. Asia Pac J Clin Oncol. 2013;9:71\u20139.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fonc.2016.00022","volume":"6","author":"L Vasquez","year":"2016","unstructured":"Vasquez L, Tarrillo F, Oscanoa M, Maza I, Geronimo J, Paredes G, Silva JM, Sialer L. Analysis of prognostic factors in high-grade osteosarcoma of the extremities in children: a 15-year single-institution experience. Front Oncol. 2016;6:22.","journal-title":"Front Oncol"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1097\/MPH.0000000000000270","volume":"37","author":"P Berlanga","year":"2015","unstructured":"Berlanga P, Canete A, Diaz R, Salom M, Baixauli F, Gomez J, Llavador M, Castel V. Presentation and long-term outcome of high-grade osteosarcoma: a single-institution experience. J Pediatr Hematol Oncol. 2015;37:e272\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/apa.12986","volume":"104","author":"J Serlo","year":"2015","unstructured":"Serlo J, Tarkkanen M, Sampo M, Vettenranta K, Riikonen P, Helenius I. Incidence, treatment and survival of paediatric patients with bone sarcomas in Finland from 1991 to 2005. Acta Paediatr. 2015;104:738\u201345.","journal-title":"Acta Paediatr"},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"e3420","DOI":"10.1097\/MD.0000000000003420","volume":"95","author":"GY Hung","year":"2016","unstructured":"Hung GY, Yen HJ, Yen CC, Wu PK, Chen CF, Chen PC, Wu HT, Chiou HJ, Chen WM. Improvement in high-grade osteosarcoma survival: results from 202 patients treated at a single institution in Taiwan. Medicine (Baltimore). 2016;95:e3420.","journal-title":"Medicine (Baltimore)"},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1200\/JCO.2005.03.5352","volume":"24","author":"AS Petrilli","year":"2006","unstructured":"Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Pericles P, Davi A, et al. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol. 2006;24:1161\u20138.","journal-title":"J Clin Oncol"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/pbc.23172","volume":"57","author":"M Hegyi","year":"2011","unstructured":"Hegyi M, Semsei AF, Jakab Z, Antal I, Kiss J, Szendroi M, Csoka M, Kovacs G. Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy. Pediatr Blood Cancer. 2011;57:415\u201322.","journal-title":"Pediatr Blood Cancer"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.ejca.2009.03.005","volume":"45","author":"EE Pakos","year":"2009","unstructured":"Pakos EE, Nearchou AD, Grimer RJ, Koumoullis HD, Abudu A, Bramer JA, Jeys LM, Franchi A, Scoccianti G, Campanacci D, et al. Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer. 2009;45:2367\u201375.","journal-title":"Eur J Cancer"},{"key":"1344_CR16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.47102\/annals-acadmedsg.V41N9p390","volume":"41","author":"SS Nathan","year":"2012","unstructured":"Nathan SS, Healey JH. Demographic determinants of survival in osteosarcoma. Ann Acad Med Singap. 2012;41:390\u20139.","journal-title":"Ann Acad Med Singap"},{"key":"1344_CR17","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1002\/cncr.27414","volume":"118","author":"KA Janeway","year":"2012","unstructured":"Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N. Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children\u2019s Oncology Group. Cancer. 2012;118:4597\u2013605.","journal-title":"Cancer"},{"key":"1344_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.canep.2015.10.016","volume":"39","author":"D Pruksakorn","year":"2015","unstructured":"Pruksakorn D, Phanphaisarn A, Arpornchayanon O, Uttamo N, Leerapun T, Settakorn J. Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: a series from Chiang Mai University Hospital. Cancer Epidemiol. 2015;39:956\u201363.","journal-title":"Cancer Epidemiol"},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1245\/s10434-014-4154-z","volume":"22","author":"GY Hung","year":"2015","unstructured":"Hung GY, Yen HJ, Yen CC, Chen WM, Chen PC, Wu HT, Chiou HJ, Chang WH, Hsu HE. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival. Ann Surg Oncol. 2015;22:1080\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1344_CR20","doi-asserted-by":"crossref","first-page":"38348","DOI":"10.18632\/oncotarget.5276","volume":"6","author":"B Wang","year":"2015","unstructured":"Wang B, Tu J, Yin J, Zou C, Wang J, Huang G, Xie X, Shen J. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma. Oncotarget. 2015;6:38348\u201359.","journal-title":"Oncotarget"},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/0284186X.2014.925139","volume":"54","author":"N Aggerholm-Pedersen","year":"2015","unstructured":"Aggerholm-Pedersen N, Maretty-Nielsen K, Keller J, Baerentzen S, Schroder H, Jorgensen PH, Hansen BH, Nielsen OS, Safwat A. The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database. Acta Oncol. 2015;54:17\u201324.","journal-title":"Acta Oncol"},{"key":"1344_CR22","doi-asserted-by":"publisher","unstructured":"Berner K, Hall KS, Monge OR, Weedon-Fekjaer H, Zaikova O, Bruland OS. Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the \u201cclassical\u201d patient. Sarcoma. 2015;2015:14. Article ID 516843. https:\/\/doi.org\/10.1155\/2015\/516843 .","DOI":"10.1155\/2015\/516843"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","volume":"20","author":"SS Bielack","year":"2002","unstructured":"Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776\u201390.","journal-title":"J Clin Oncol"},{"key":"1344_CR24","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.","edition":"7"},{"key":"1344_CR25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cncr.21724","volume":"106","author":"G Bacci","year":"2006","unstructured":"Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer. 2006;106:1154\u201361.","journal-title":"Cancer"},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1023\/A:1011636912674","volume":"12","author":"S Ferrari","year":"2001","unstructured":"Ferrari S, Bertoni F, Mercuri M, Picci P, Giacomini S, Longhi A, Bacci G. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol. 2001;12:1145\u201350.","journal-title":"Ann Oncol"},{"key":"1344_CR27","doi-asserted-by":"crossref","unstructured":"Faisham WI, Mat Saad AZ, Alsaigh LN, Nor Azman MZ, Kamarul Imran M, Biswal BM, Bhavaraju VM, Salzihan MS, Hasnan J, Ezane AM, et al. Prognostic factors and survival rate of osteosarcoma: A single-institution study. Asia Pac J Clin Oncol. 2017;13:e104\u201310.","DOI":"10.1111\/ajco.12346"},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.canep.2015.05.001","volume":"39","author":"KR Duchman","year":"2015","unstructured":"Duchman KR, Gao Y, Miller BJ. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database. Cancer Epidemiol. 2015;39:593\u20139.","journal-title":"Cancer Epidemiol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1344-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:22:20Z","timestamp":1693552940000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1344-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1344-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"16 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Nanfang Hospital Ethics Review Board with the consent of each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"39"}}